In a liver cancer mouse model SIRT6 has a tumor suppression effect, repressing the transcription of survivin at two levels: through H3K9 deacetylation at its promoter and through NF-κB deacetylation, which impairs its binding to survivin promoter [39]. Here, BIRC5 is linked to liver cancer.